A scientific statement regarding CPET interpretation in patients with congenital HD across their lifespan has been published by the AHA.

Patients are significantly more likely to experience treatment-related cardiac events with osimertinib than with other EGFR TKIs, data suggest.

Maintaining ideal cardiovascular health may lower the risk for all-cause mortality among patients with arthritis.

Experiencing at least one microaggression related to race and gender during or after pregnancy is associated with increased postpartum blood pressure (BP).

In patients with acute aortic dissection with poor preoperative sleep quality, there is increased risk for adverse clinical outcomes.

A discussion of the essential role that primary care physicians play in the management of patients’ overall and cardiovascular health.

The FDA has accepted for review the New Drug Application for plozasiran for the treatment for familial chylomicronemia syndrome.

Older cancer decedents with an implantable cardioverter defibrillator (ICD) receive more aggressive end-of-life care.

The current director of the National Institutes of Health, Monica M. Bertagnolli, M.D., has announced that she will step down from the position on Friday, Jan. 17, 2025.

A study has found that convenient access to a nearby major park in young adulthood may improve cardiovascular health in midlife.

Cancer mortality is continuing to decline, but the incidence of certain cancer types is increasing, especially among women, according to the Cancer Statistics.

Teams of researchers are investigating empagliflozin and dapagliflozin in patients with autosomal dominant polycystic kidney disease (AD PKD).